tiprankstipranks
Revive Therapeutics Ltd (TSE:RVV)
CNQX:RVV
Holding TSE:RVV?
Track your performance easily

Revive Therapeutics (RVV) Financial Statements

127 Followers

Revive Therapeutics Financial Overview

Revive Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.014; its P/E ratio is -0.70; Revive Therapeutics is scheduled to report earnings on November 28, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----C$ -405.38K
Gross Profit----C$ -405.38K
EBIT-C$ -1.87MC$ -764.72KC$ -383.14KC$ -1.16M
EBITDA-C$ -1.87MC$ -764.64KC$ -383.06KC$ -1.16M
Net Income Common Stockholders-C$ -1.87MC$ -770.62KC$ -390.62KC$ -1.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 773.07KC$ 1.05MC$ 708.41KC$ 1.59MC$ 2.09M
Total AssetsC$ 10.64MC$ 13.14MC$ 12.88MC$ 13.78MC$ 14.25M
Total DebtC$ 25.22KC$ 61.51KC$ 156.05KC$ 188.91KC$ 219.69K
Net DebtC$ -747.85KC$ -987.89KC$ -552.37KC$ -1.40MC$ -1.87M
Total LiabilitiesC$ 3.40MC$ 3.33MC$ 3.35MC$ 3.52MC$ 3.60M
Stockholders EquityC$ 7.23MC$ 9.82MC$ 9.53MC$ 10.26MC$ 10.65M
Cash Flow-
Free Cash Flow-C$ -1.64MC$ -883.42KC$ -495.53KC$ -568.09K
Operating Cash Flow-C$ -1.64MC$ -883.42KC$ -495.53KC$ -568.09K
Investing Cash Flow-C$ -40.00K---
Financing Cash Flow-C$ 2.02M---
Currency in CAD

Revive Therapeutics Earnings and Revenue History

Revive Therapeutics Debt to Assets

Revive Therapeutics Cash Flow

Revive Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis